Gaucher App , PTV News: May 25, 2010




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Gaucher App , PTV News: May 25, 2010
Released on: May 25, 2010. © PharmaVentures Ltd
Visitors: You are watching a 1 minute preview.
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
  • Summary
  • Transcript
  • Participants
  • Company
Shire launches iPhone application to pile pressure on Genzyme
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Steven Renwick
Advisor
PharmaVentures

Steven is a transactions specialist with experience in asset divestments and IP screening and sourcing, as well as competitive analysis and licensing litigation cases wherein PharmaVentures served as expert witness. He also conducts research on industry licensing practices and has presented this work internationally. Previously, Steven managed PharmaVentures’ Strategic Intelligence division, with responsibility for the development and production of PharmaDeals®. Steven has a BSc (Hons) in Biochemistry from the University of Dundee and a PhD in Genetics from University College London.
Genzyme
Genzyme Corporation is a biotechnology company based in Cambridge, Massachusetts. Genzyme is the world’s third-largest biotechnology company, employing more than 11,000 people around the world. The company has a presence in approximately 40 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories, its products are sold in 90 countries.
PharmaVentures Ltd
PharmaVentures is a company that has proven success in deals and alliances.

PharmaVentures offers:


• Over 18 years of healthcare industry experience

• Experience gained from working with in excess of 1000 clients in 38 countries, and conducting more than 450 assignments

• Over 40 specialist advisors, analysts and researchers

• Skills honed in many countries - 80% of its business comes from outside the UK
Shire
As one of the world’s leading specialty biopharmaceutical companies, Shire has emerged as a company fully focused on a single purpose: to enable people with life-altering conditions to lead better lives. Shire is a global company with offices in the major pharmaceutical markets. Its UK offices are in Basingstoke and its US offices are in Wayne, Pennsylvania.